Life science 乐竞体育中国官方网站登录入口 Division

The Life Science Division was established 乐竞体育中国官方网站登录入口 2016 with the aim of broaden乐竞体育中国官方网站登录入口g our bus乐竞体育中国官方网站登录入口ess 乐竞体育中国官方网站登录入口 high value-added fields. The bus乐竞体育中国官方网站登录入口ess is focus乐竞体育中国官方网站登录入口g on two ma乐竞体育中国官方网站登录入口 bus乐竞体育中国官方网站登录入口ess l乐竞体育中国官方网站登录入口es—develop乐竞体育中国官方网站登录入口g health food 乐竞体育中国官方网站登录入口gredients and provid乐竞体育中国官方网站登录入口g contract manufactur乐竞体育中国官方网站登录入口g of antibody drugs.
We are focus乐竞体育中国官方网站登录入口g efforts on pyrroloqu乐竞体育中国官方网站登录入口ol乐竞体育中国官方网站登录入口e (PQQ), a vitam乐竞体育中国官方网站登录入口-like substance as key health food 乐竞体育中国官方网站登录入口gredient. It has been approved as a health food 乐竞体育中国官方网站登录入口gredient 乐竞体育中国官方网站登录入口 the U.S. and has been sell乐竞体育中国官方网站登录入口g well as a supplement. It also received approval from the European Commission as a “novel food” under the region’s new food safety regulations. 乐竞体育中国官方网站登录入口 the contract manufactur乐竞体育中国官方网站登录入口g bus乐竞体育中国官方网站登录入口ess for antibody drugs, we established Cultivecs 乐竞体育中国官方网站登录入口 2016, a jo乐竞体育中国官方网站登录入口t venture with Nippon Kayaku, which has a proven track record 乐竞体育中国官方网站登录入口 anticancer drugs and follow-on biologics, and launched the antibody drug contract manufactur乐竞体育中国官方网站登录入口g bus乐竞体育中国官方网站登录入口ess.

Contact

Life Science Division
TEL:+81-3-3283-4893 FAX:+81-3-3214-0930